PubMed · 1995 · 38 citations · 0 references
MedicineHematologyPharmacotherapyCrisis InterventionInfectious Disease PharmacotherapyOutcomes ResearchAnemiaSickle Cell DiseaseZinc DeficiencyZinc NutritionControl Group DesignHospital Stay DurationMatched Control GroupSickle Cell AnemiaZinc Chelation TherapyZinc Deficiency Prevention
145 patients were recruited in the trial while 130 completed it. Patients were randomized to receive zinc sulphate capsules. 220 mgm three times a day or identical placebo. Major outcome variable was 'Sickle cell crisis'. After a follow up of 1.5 years, the mean number of episodes of crisis was 2.46 +/- 1.04 in the intervention group and 5.29 +/- 2.58 in the control group (p < 0.025; 95% CI for difference between groups: 1.98, 3.42). Mean duration of hospital stay was 4.3 +/- 2.2 days in the intervention group and 3.9 +/- 1.6 days in the control group. The difference was not significant (p > 0.05). There was a significant reduction of the mean number of infective episodes and associated morbidity in patients with sickle cell anaemia.